Boston Scientific’s deal to acquire Shockwave Medical reportedly hits a snag

Michael Walter | May 08, 2023 | Cardiovascular Business | Mergers & Acquisitions

Intravascular lithotripsy (IVL) Shockwave Medical PCI PAD CAD trial prsented at SCAI 2022. #DisruptPAD, #DisruptCAD, #SCAI #SCAI22 #SCAI2022

Image courtesy of Shockwave Medical.

Boston Scientific has been exploring a potential acquisition of Shockwave Medical, the California-based healthcare company known for its intravascular lithotripsy (IVL) technology, but those talks may have reached a standstill.

According to a new report from StreetInsider, a source close to the situation has revealed that Boston Scientific and Shockwave Medical are unable to agree on a price. Traders certainly took the source’s insights seriously: Shockwave Medical’s stock price fell more than 6% as a result of the report, and Boston Scientific’s stock price jumped nearly 3%.

When Bloomberg first reported on the situation, the site speculated that Boston Scientific acquiring Shockwave Medical would be one of the biggest deals in Boston Scientific’s history, rivaled only by a 2006 deal the company made to acquire Guidant Corp. for more than $27 billion.

Shockwave Medical making an impression

Shockwave Medical has made a significant impression on the interventional cardiology space in recent years thanks to the success of its IVL technology, which is now approved by the U.S. Food and Drug Administration for the treatment of both severely calcified coronary artery disease and peripheral artery disease.

Also, when the Society for Cardiovascular Angiography and Interventions (SCAI) issued updated recommendations saying severely calcified lesions could be treated at facilities with no on-site surgical backup, this opened the door for coronary IVL to be performed at every cath lab in the United States.

The company is expected to share its latest earnings data late Monday, May 8, after the market has closed for the day. In addition, a “fireside chat” featuring the company’s management team has been announced for Wednesday, May 10, at the BofA Securities 2023 Healthcare Conference.

Avertix Medical, known for its implantable heart attack detection devices, to go public with initial value of $195M

Report: Boston Scientific considering massive deal to acquire interventional cardiology specialists Shockwave Medical

Interventional cardiologists can safely perform PCI without on-site surgical backup

Shockwave Medical to acquire medical device company for $100M

VIDEO: Shockwave Medical demonstrates faster intravascular lithotripsy at ACC.22

Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Around the web

Health Imaging

Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging

New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business

What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."